ibandronic acid

The drug is prescribed to adults for the prevention of bone damage (fractures, lesions requiring surgery or radiation therapy) in patients with breast cancer that has spread to the bones. It is also used to treat hypercalcemia (elevated calcium levels) in malignant neoplasms.

Form: concentrate for infusion solution

ATC: M05BA06

Manufacturer: Farmaten SA

The drug is prescribed for adults for the prevention of skeletal events (pathological fractures, bone lesions requiring surgery or radiotherapy) in patients with breast cancer and bone metastases.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: Farmaten SA

The drug is intended for the treatment of osteoporosis in postmenopausal women with an increased risk of fractures.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: Farmaten SA

The drug is used to prevent bone damage (e.g., pathological fractures) in patients with breast cancer that has metastasized to the bones. It is also prescribed for the treatment of hypercalcemia (elevated calcium levels) in malignant neoplasms.

Form: concentrate for infusion solution

ATC: M05BA06

Manufacturer: Roche Diagnostics GmbH (full-cycle manufacturing)

The drug is used for the prevention of bone damage (pathological fractures and lesions requiring surgery or radiotherapy) in patients with breast cancer and bone metastases.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: F. Hoffmann-La Roche Ltd (manufacturing unpackaged products, quality control testing, batch release, primary and secondary packaging)

The drug is intended for the treatment of osteoporosis in postmenopausal women who are at an increased risk of fractures.

Form: solution for injection

ATC: M05BA06

Manufacturer: Synthon Hispania, S.L. (batch release, quality control (physico-chemical))

The drug is used for the treatment of osteoporosis in postmenopausal women who are at an increased risk of fractures.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: F. Hoffmann-La Roche Ltd (manufacturing of unpackaged products, quality control testing, batch release, primary and secondary packaging, quality control testing)

The drug is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures.

Form: solution for injection

ATC: M05BA06

Manufacturer: Wetter Pharma-Fertigung GmbH & Co. KG (manufacturing of unpackaged products, primary packaging)

The drug is used to prevent bone damage (e.g., pathological fractures) in patients with breast cancer that has spread to the bone tissue. It is also prescribed for the treatment of hypercalcemia (elevated calcium levels) in malignant neoplasms.

Form: concentrate for infusion solution

ATC: M05BA06

Manufacturer: Farmex Group LLC

The drug is intended for the treatment of osteoporosis in postmenopausal women who are at an increased risk of fractures.

Form: solution for injection

ATC: M05BA06

Manufacturer: Farmex Group LLC

The drug is used to prevent bone damage (pathological fractures and bone lesions requiring surgical intervention or radiotherapy) in patients with breast cancer and bone metastases.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: Synthon Hispania, S.L.

The drug is intended for the treatment of osteoporosis in postmenopausal women who are at an increased risk of fractures.

Form: tablets, film-coated

ATC: M05BA06

Manufacturer: Synthon Hispania, S.L.

The drug is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures.

Form: solution for injection

ATC: M05BA06

Manufacturer: K.T. ROMFARM COMPANY S.R.L. (Quality control of starting and packaging materials, intermediate and unpackaged products, finished medicinal product, secondary packaging of medicinal product, certification and batch release; Manufacturing and primary packaging of medicinal product)